K210623

Substantially Equivalent

FLC Kappa, FLC Lambda, FLC Control Level 1, FLC Control Level 2

Applicant: Sebia
Product code: DFH
Advisory panel: Immunology
Date received: 2021-03-02
Decision date: 2022-11-18
Decision: Substantially Equivalent
Clearance type: Traditional
Location: Norcross, GA, US

Download summary PDF View on FDA.gov ↗

Data sourced from openFDA. This site is unofficial and independent of the FDA.